Emfogen M XR 10 mg+1000 mg (Tablet (Extended Release))

Unit Price: ৳ 30.00 (2 x 6: ৳ 360.00)
Strip Price: ৳ 180.00

Medicine Details

Indications

  • Treatment of type 2 diabetes mellitus in adults
  • Adjunct to diet and exercise
  • Insufficiently controlled on maximally tolerated dose of Metformin alone
  • Combination with other medicinal products for diabetes
  • Already being treated with the combination of Empagliflozin and Metformin as separate tablets

Pharmacology

  • Inhibitor of Sodium-Glucose Co-Transporter 2 (SGLT2)
  • Reduces renal reabsorption of filtered glucose
  • Lowers renal threshold for glucose
  • Increases urinary glucose excretion
  • Biguanide type oral antihyperglycemic drug
  • Lowers basal and postprandial plasma glucose
  • Does not produce hypoglycemia
  • Decreases hepatic glucose production
  • Decreases intestinal absorption of glucose
  • Improves insulin sensitivity

Dosage & Administration

  • Individualized dosage based on effectiveness and tolerability
  • Take twice daily with meals
  • Gradual dose escalation to reduce gastrointestinal side effects
  • Extended-release formulations available
  • Dose adjustment for renal impaired patients
  • Not recommended for pediatric patients under 18 years of age

Interactions

  • Diuretics
  • Insulin or Insulin Secretagogues
  • Positive Urine Glucose Test
  • Drugs that reduce Metformin clearance
  • Carbonic Anhydrase Inhibitors
  • Drugs affecting glycemic control
  • Alcohol

Contraindications

  • Hypersensitivity to Empagliflozin and Metformin
  • Acute metabolic acidosis
  • Diabetic pre-coma
  • Severe renal failure
  • Acute conditions altering renal function
  • Conditions causing tissue hypoxia
  • Hepatic impairment
  • Acute alcohol intoxication
  • Alcoholism

Side Effects

  • Urinary tract infection
  • Female genital mycotic infections
  • Diarrhea
  • Nausea/vomiting
  • Flatulence
  • Abdominal discomfort
  • Indigestion
  • Asthenia
  • Headache
  • Hypoglycemia
  • Vaginal moniliasis
  • Urinary tract infection
  • Thirst
  • Taste disturbance
  • Pruritus
  • Rash
  • Increased urination
  • Serum lipids increased
  • Volume depletion
  • Urticaria
  • Dysuria
  • Blood creatinine increased/Glomerular filtration rate decreased
  • Haematocrit increased
  • Diabetic ketoacidosis

Pregnancy & Lactation

  • Potential risk to fetus
  • Not recommended during breastfeeding

Precautions & Warnings

  • Lactic Acidosis
  • Hypotension
  • Ketoacidosis
  • Acute kidney injury & impairment in renal function
  • Urosepsis, Pyelonephritis, Fournier’s gangrene & Genital mycotic infections
  • Hypoglycemia
  • Vitamin B12 Deficiency
  • Increased LDL-C
  • Macrovascular Outcomes

Overdose Effects

  • No toxicity with controlled standard doses
  • Hypoglycemia
  • Lactic acidosis
  • Medical emergency
  • Treatment in hospital
  • Haemodialysis for lactic acidosis

Therapeutic Class

  • Oral hypoglycemic preparations

Storage Conditions

  • Keep below 30°C temperature
  • Protected from light & moisture
  • Keep out of the reach of children

Related Brands